BiotechTube
Home/Lumos Diagnostics/Sam Lanyon
SL

Sam Lanyon

Non-Executive Chair

Lumos Diagnostics

Therapeutic Areas

Infectious DiseaseInflammatory Disease

Lumos Diagnostics Pipeline

DrugIndicationPhase
FebriDxDifferentiation of bacterial vs. non-bacterial infection (Acute Respiratory Infections)Commercial
ViraDxSimultaneous detection of SARS-CoV-2, Influenza A, Influenza BCommercial
Leelu ReaderDigital quantification platform for lateral flow assaysCommercial

Leadership Team at Lumos Diagnostics

DW
Doug Ward
CEO and Managing Director
BL
Bronwyn Le Grice
Non-Executive Director
LM
Lawrence Mehren
Non-Executive Director
CR
Catherine Robson
Non-Executive Director
View full Lumos Diagnostics profile